| ID | 10369 |
| Vaccine Name | SYN023 (Freeze-dried Rabies Vaccine for Human Use (Vero Cells)) |
| Disease Name | Rabies |
| Disease Classification | Neurologic |
| Virus Name | Rabies virus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | NA |
| Vaccine Status | Phase 3 |
| Manufacturer | Synermore Biologics (Suzhou) Co. Ltd. |
| Year of Manufacturing | 2020 |
| Manufacturing Country | China |
| Age | 18 years and above |
| Dosage | 5 doses on day 1, 4, 8, 15 and 29 |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | Simoon Record Pharma Information Consulting Co. Ltd., Clinchoice Inc. |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04644484 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT04644484?cond=Rabies+Human&phase=23&draw=2&rank=4 |
| Additional Links | NA
|